China Health Group Limited (HKG:0673)
Hong Kong · Delayed Price · Currency is HKD 0.8000
-0.0100 (-1.23%)
Jan 21, 2026, 3:42 PM HKT
China Health Group Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 39.87 | 38.94 | 59.93 | 76.41 | 107.03 | 87.89 | Upgrade | |
Revenue Growth (YoY) | -20.80% | -35.02% | -21.57% | -28.60% | 21.77% | 94.62% | Upgrade |
Cost of Revenue | 30.78 | 29.71 | 46.29 | 49.22 | 78.34 | 61.9 | Upgrade |
Gross Profit | 9.09 | 9.24 | 13.64 | 27.19 | 28.69 | 25.99 | Upgrade |
Selling, General & Admin | 65.83 | 68.83 | 50.23 | 39.99 | 39.22 | 37.28 | Upgrade |
Other Operating Expenses | -16.54 | -16.54 | -37.7 | - | - | - | Upgrade |
Operating Expenses | 49.29 | 52.29 | 12.53 | 40.02 | 39.99 | 38.17 | Upgrade |
Operating Income | -40.2 | -43.06 | 1.11 | -12.82 | -11.3 | -12.18 | Upgrade |
Interest Expense | -1.23 | -0.25 | -0.33 | -2.19 | -0.29 | -0.29 | Upgrade |
Interest & Investment Income | - | 0.01 | 0.92 | 0.44 | 0.33 | 5.14 | Upgrade |
Earnings From Equity Investments | - | - | - | -4 | - | - | Upgrade |
Other Non Operating Income (Expenses) | 4.4 | - | - | -3.35 | -1.9 | 1.99 | Upgrade |
EBT Excluding Unusual Items | -37.02 | -43.3 | 1.7 | -21.92 | -13.16 | -5.34 | Upgrade |
Merger & Restructuring Charges | - | - | -1.33 | - | -0.3 | - | Upgrade |
Impairment of Goodwill | -11.75 | -11.75 | -13.83 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | -17.64 | -17.64 | -18.44 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -2.42 | - | 3.31 | -0.23 | - | 0.01 | Upgrade |
Other Unusual Items | 8.17 | 5.31 | -13.7 | -17.23 | 4.75 | - | Upgrade |
Pretax Income | -60.66 | -67.38 | -42.29 | -39.38 | -8.71 | -5.33 | Upgrade |
Income Tax Expense | 0.38 | 0.44 | 0.2 | 0.18 | 0.41 | 1.23 | Upgrade |
Earnings From Continuing Operations | -61.04 | -67.82 | -42.5 | -39.56 | -9.11 | -6.56 | Upgrade |
Minority Interest in Earnings | 0.03 | 0.03 | 2.31 | -2.49 | -3.09 | -1.19 | Upgrade |
Net Income | -61.01 | -67.79 | -40.19 | -42.05 | -12.21 | -7.74 | Upgrade |
Net Income to Common | -61.01 | -67.79 | -40.19 | -42.05 | -12.21 | -7.74 | Upgrade |
Shares Outstanding (Basic) | 487 | 487 | 475 | 427 | 412 | 412 | Upgrade |
Shares Outstanding (Diluted) | 487 | 487 | 475 | 427 | 412 | 412 | Upgrade |
Shares Change (YoY) | 0.43% | 2.51% | 11.46% | 3.48% | - | - | Upgrade |
EPS (Basic) | -0.13 | -0.14 | -0.08 | -0.10 | -0.03 | -0.02 | Upgrade |
EPS (Diluted) | -0.13 | -0.14 | -0.08 | -0.10 | -0.03 | -0.02 | Upgrade |
Free Cash Flow | 5.58 | -8.35 | -7.03 | -20.98 | 31.15 | -10.84 | Upgrade |
Free Cash Flow Per Share | 0.01 | -0.02 | -0.01 | -0.05 | 0.08 | -0.03 | Upgrade |
Gross Margin | 22.80% | 23.71% | 22.76% | 35.59% | 26.81% | 29.57% | Upgrade |
Operating Margin | -100.82% | -110.56% | 1.85% | -16.78% | -10.56% | -13.86% | Upgrade |
Profit Margin | -153.00% | -174.07% | -67.06% | -55.02% | -11.40% | -8.81% | Upgrade |
Free Cash Flow Margin | 14.00% | -21.45% | -11.72% | -27.46% | 29.10% | -12.34% | Upgrade |
EBITDA | -37.77 | -40.66 | 3.98 | -10.11 | -8.38 | -9.59 | Upgrade |
EBITDA Margin | -94.73% | -104.41% | 6.64% | -13.23% | -7.83% | -10.91% | Upgrade |
D&A For EBITDA | 2.43 | 2.4 | 2.87 | 2.72 | 2.92 | 2.59 | Upgrade |
EBIT | -40.2 | -43.06 | 1.11 | -12.82 | -11.3 | -12.18 | Upgrade |
EBIT Margin | -100.82% | -110.56% | 1.85% | -16.78% | -10.56% | -13.86% | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.